Common drug recalled in Spain

Common drug recalled in Spain by the Spanish Agency for Medicines and Health Products.

The Spanish Agency for Medicines and Health Products (AEMPS), which reports to the Ministry of Health, has made the decision to recall two batches of omeprazole. The recall has been made because of the “possible release of silica gel granules into the bottles due to a defect in the closure of the reservoir of this desiccant”.

According to Aemps, “the recall is for omeprazole TEVA 40 mg Hard Gastroresistant Capsules, 56 capsules in bottle, batch 16738 and expiry date 30/06/2022; and omeprazole TEVA-Rimafar 20 mg Hard Gastroresistant Capsules EFG, 56 capsules, batch 16873 and expiry date 30/06/2022”, as reported 20 minutes.

The products have been withdrawn from the market and it is expected that any units that have been distributed from the affected batches will be returned by the usual channels. Anyone worried about the medications that they are taking should head to see their doctor or their nearest pharmacist.

In other medication news in Spain, blood pressure drug recalled in Spain. The Spanish Agency for Medicines and Health Products (Aemps) have recalled a popular blood pressure drug in Spain due to the presence of impurities.

The Spanish Agency for Medicines and Health Products (Aemps) reports to Spain’s Ministry of Health and they have ordered that a batch of Karvezide 300mg is recalled. The drug is a blood pressure medicine and it has been found to contain impurities that are said to be above the acceptable limits. The impurities have been found in the active ingredient which is called irbersartan.

It was only last week that another recall was issued for several batches of batches of Irbesartan Normon and Coaprovel, two drugs also used to treat high blood pressure.

Thank you for reading, and don’t forget to check The Euro Weekly News for all your up-to-date local and international news stories.